We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Rithm Capital
RITM
$5.79B
| $1.4M | 0.01% |
123,194
+11,700
| +10% | +$133K |
|
802
Dropbox
DBX
$7.81B
| $1.4M | 0.01% |
54,900
| – | – |
|
803
Acadia Healthcare
ACHC
$2.82B
| $1.39M | 0.01% |
21,874
+3,800
| +21% | +$274K |
|
804
Kontoor Brands
KTB
$4.65B
| $1.38M | 0.01% |
16,892
| – | – |
|
|
CFLT
805
DELISTED
Confluent
CFLT
| $1.38M | 0.01% |
67,692
+22,000
| +48% | +$493K |
|
806
Commault Systems
CVLT
$6.26B
| $1.37M | 0.01% |
8,930
| – | – |
|
807
Haemonetics
HAE
$4.11B
| $1.37M | 0.01% |
17,095
+3,300
| +24% | +$267K |
|
808
Installed Building Products
IBP
$6.54B
| $1.37M | 0.01% |
5,565
| – | – |
|
809
Unity
U
$20.2B
| $1.37M | 0.01% |
60,500
+10,200
| +20% | +$176K |
|
810
Highwoods Properties
HIW
$3.51B
| $1.37M | 0.01% |
40,823
+3,700
| +10% | +$113K |
|
811
Rambus
RMBS
$10.8B
| $1.37M | 0.01% |
32,397
+8,200
| +34% | +$397K |
|
812
CRISPR Therapeutics
CRSP
$5.22B
| $1.37M | 0.01% |
29,100
-71,200
| -71% | -$3.61M |
|
813
Glacier Bancorp
GBCI
$6.48B
| $1.36M | 0.01% |
29,874
+6,200
| +26% | +$268K |
|
|
BCPC
814
Balchem Corp
BCPC
$5.65B
| $1.36M | 0.01% |
7,751
+400
| +5% | +$68.1K |
|
815
Ultragenyx Pharmaceutical
RARE
$2.6B
| $1.36M | 0.01% |
24,523
+3,200
| +15% | +$163K |
|
816
Popular Inc
BPOP
$11.3B
| $1.36M | 0.01% |
13,539
| – | – |
|
817
CareTrust REIT
CTRE
$9.18B
| $1.35M | 0.01% |
43,846
+17,800
| +68% | +$504K |
|
818
Frontdoor
FTDR
$5.83B
| $1.35M | 0.01% |
28,200
+11,100
| +65% | +$481K |
|
819
H.B. Fuller
FUL
$3.24B
| $1.35M | 0.01% |
17,016
+200
| +1% | +$16.2K |
|
820
Dycom Industries
DY
$12.3B
| $1.35M | 0.01% |
6,851
+1,500
| +28% | +$271K |
|
821
Impinj
PI
$5.46B
| $1.34M | 0.01% |
6,200
| – | – |
|
822
FNB Corp
FNB
$6.88B
| $1.33M | 0.01% |
94,631
+17,800
| +23% | +$254K |
|
823
Invesco
IVZ
$14.3B
| $1.33M | 0.01% |
75,800
| – | – |
|
824
AerCap
AER
$23.5B
| $1.32M | 0.01% |
13,991
-3,331
| -19% | -$312K |
|
825
Chewy
CHWY
$9.2B
| $1.32M | 0.01% |
45,100
+5,100
| +13% | +$136K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.